Clinical Trial Update: Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

View source ↗

Summary

A clinical trial update from Taiwan describes pharmacogenetic profiling related to antipsychotic-induced X-Syndrome and diabetes, with relevance to metabolic sy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Metabolic Syndrome

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Metabolic Syndrome, Diabetes | Status: UNKNOWN